It was suggested that Th9 cells may prevent GVHD in an experiment that showed in a murine allogeneic model, mice treated with a co-transfer of rapamycin resistant Th9 cells showed decreased donor CD8+ cell engraftment and decreased donor IFN-γ production (130). Here, IFNG is linked to graft versus host disease.